Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice
Authors:
- 15 May 2016
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 310 (10) , E855-E861
Abstract
Roux-en-Y gastric bypass (RYGB) causes profound weight loss and remission of diabetes by influencing metabolic physiology, yet the mechanisms behind these clinical improvements remain undefined. After RYGB, levels of glucagon-like peptide-1 (GLP-1), a hormone that enhances insulin secretion and promotes satiation, are substantially elevated. Because GLP-1 signals in both the periphery and the brain to influence energy balance and glucose regulation, we aimed to determine the relative requirements of these systems to weight loss and improved glucose tolerance following RYGB surgery in mice. By pharmacologically blocking peripheral or central GLP-1R signaling, we examined whether GLP-1 action is necessary for the metabolic improvements observed after RYGB. Diet-induced obese mice underwent RYGB or sham operation and were implanted with osmotic pumps delivering the GLP-1R antagonist exendin-(9–39) (2 pmol·kg−1·min−1 peripherally; 0.5 pmol·kg−1·min−1 centrally) for up to 10 wk. Blockade of peripheral GLP-1R signaling partially reversed the improvement in glucose tolerance after RYGB. In contrast, fasting glucose and insulin sensitivity, as well as body weight, were unaffected by GLP-1R antagonism. Central GLP-1R signaling did not appear to be required for any of the metabolic improvements seen after this operation. Collectively, these results suggest a detectable but only modest role for GLP-1 in mediating the effects of RYGB and that this role is limited to its well-described action on glucose regulation.Keywords
This publication has 34 references indexed in Scilit:
- Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and AdiposityScience Translational Medicine, 2013
- Melanocortin-4 Receptor Signaling Is Required for Weight Loss after Gastric Bypass SurgeryThe Journal of Clinical Endocrinology & Metabolism, 2012
- Bariatric Surgery versus Conventional Medical Therapy for Type 2 DiabetesNew England Journal of Medicine, 2012
- Gastric bypass reduces fat intake and preferenceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Weight-Independent Changes in Blood Glucose Homeostasis After Gastric Bypass or Vertical Sleeve Gastrectomy in RatsGastroenterology, 2011
- Gastric Bypass Surgery Enhances Glucagon-Like Peptide 1–Stimulated Postprandial Insulin Secretion in HumansDiabetes, 2011
- Meal-Induced Hormone Responses in a Rat Model of Roux-en-Y Gastric Bypass SurgeryEndocrinology, 2010
- Endogenous Hindbrain Glucagon-Like Peptide-1 Receptor Activation Contributes to the Control of Food Intake by Mediating Gastric Satiation SignalingEndocrinology, 2009
- Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food IntakeDiabetes, 2008
- Effect of Weight Loss by Gastric Bypass Surgery Versus Hypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2008